119 related articles for article (PubMed ID: 10823421)
21. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response.
Ross ME; Caligiuri MA
Blood; 1997 Feb; 89(3):910-8. PubMed ID: 9028322
[TBL] [Abstract][Full Text] [Related]
23. Modulation of natural killer cell function leading to spontaneous regression of a histiocytoma.
Bright JJ; Hegde SP; Begum Z; Khar A
Cell Immunol; 1994 Mar; 154(1):54-65. PubMed ID: 8118890
[TBL] [Abstract][Full Text] [Related]
24. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
25. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression.
Matter-Reissmann UB; Forte P; Schneider MK; Filgueira L; Groscurth P; Seebach JD
Xenotransplantation; 2002 Sep; 9(5):325-37. PubMed ID: 12199864
[TBL] [Abstract][Full Text] [Related]
26. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.
Zamai L; Ahmad M; Bennett IM; Azzoni L; Alnemri ES; Perussia B
J Exp Med; 1998 Dec; 188(12):2375-80. PubMed ID: 9858524
[TBL] [Abstract][Full Text] [Related]
27. AK cells were developed from NK cells during in vitro culture of allogeneic or F1 anti-parental stimulation: functional conversion in recognizing H-2 expression of target cells accompanied by phenotypical conversion.
Taniguchi K; Kawano YI; Nomoto K
Immunology; 1988 Aug; 64(4):669-76. PubMed ID: 2971609
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cell as the effector which mediates in vivo apoptosis in AK-5 tumor cells.
Khar A; Pardhasaradhi BV; Varalakshmi C; Ali AM; Kumari AL
Cell Immunol; 1997 Apr; 177(1):86-92. PubMed ID: 9140099
[TBL] [Abstract][Full Text] [Related]
29. AK-5 tumor-induced modulation of host immune function: upregulation of Th-1-type cytokine response mediates early tumor regression.
Khar A; Kausalya S; Kamal MA
Cytokines Mol Ther; 1996 Mar; 2(1):39-46. PubMed ID: 9384688
[TBL] [Abstract][Full Text] [Related]
30. Activation of natural killer cells by hepatitis C virus particles in vitro.
Farag MM; Weigand K; Encke J; Momburg F
Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
[TBL] [Abstract][Full Text] [Related]
32. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
Brunda MJ; Tarnowski D; Davatelis V
Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
[TBL] [Abstract][Full Text] [Related]
33. Fas involvement in human NK cell apoptosis: lack of a requirement for CD16-mediated events.
Ortaldo JR; Winkler-Pickett RT; Nagata S; Ware CF
J Leukoc Biol; 1997 Feb; 61(2):209-15. PubMed ID: 9021927
[TBL] [Abstract][Full Text] [Related]
34. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
Jewett A; Bonavida B
Clin Immunol; 2000 Jul; 96(1):19-28. PubMed ID: 10873424
[TBL] [Abstract][Full Text] [Related]
35. Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells.
Cavalcanti M; Jewett A; Bonavida B
Int J Oncol; 1999 Feb; 14(2):361-6. PubMed ID: 9917514
[TBL] [Abstract][Full Text] [Related]
36. Administration of anti-IL-12 antibody in vivo inhibits rejection of a rat histiocytoma and suppresses cytokine response in a tumour-bearing host.
Rao KL; Varalakshmi C; Ali AM; Khar A
Immunology; 1997 Nov; 92(3):381-7. PubMed ID: 9486112
[TBL] [Abstract][Full Text] [Related]
37. Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
Gleason MK; Verneris MR; Todhunter DA; Zhang B; McCullar V; Zhou SX; Panoskaltsis-Mortari A; Weiner LM; Vallera DA; Miller JS
Mol Cancer Ther; 2012 Dec; 11(12):2674-84. PubMed ID: 23075808
[TBL] [Abstract][Full Text] [Related]
38. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
39. c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors.
Klefstrom J; Kovanen PE; Somersalo K; Hueber AO; Littlewood T; Evan GI; Greenberg AH; Saksela E; Timonen T; Alitalo K
Oncogene; 1999 Apr; 18(13):2181-8. PubMed ID: 10327064
[TBL] [Abstract][Full Text] [Related]
40. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells.
Jewett A; Bonavida B
J Immunol; 1996 Feb; 156(3):907-15. PubMed ID: 8558016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
